SCNI
Scinai Immunotherapeutics
SCNI
SCNI
4 hedge funds and large institutions have $45.2K invested in Scinai Immunotherapeutics in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$23.1K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$229 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $40.2K | -$23.1K | -8,556 | -36% |
|
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $4.17K | -$229 | -86 | -5% |
|
3
Morgan Stanley
New York
| $687 | – | – | – |
|
4
Credit Agricole
Montrouge Cedex,
France
| $113 | – | – | – |
|